Artwork

Sisällön tarjoaa SWI swissinfo.ch. SWI swissinfo.ch tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Summer profiles: unlocking treatment for neglected diseases

28:42
 
Jaa
 

Manage episode 430311887 series 2789582
Sisällön tarjoaa SWI swissinfo.ch. SWI swissinfo.ch tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Send us a text

On Inside Geneva, we bring you part three of our summer profile series. This week we talk to a doctor looking for treatments for some of the world’s most neglected diseases.
“Neglect means that there are diseases that affect an important proportion of humanity but for which no new drugs have been developed because there is no money in it. Because they affect very poor populations in remote rural areas,” explains Olaf Valverde, clinical project leader at Drugs for Neglected Diseases (DNDi).

Valverde is the clinical lead on a project looking for treatments for sleeping sickness.

“It’s a disease caused by a small parasite that almost always kills if untreated. During the first half of the 20th century there were huge epidemics. It not only destroyed communities but also caused the desertification of entire regions of Africa,” he adds.

Cases of sleeping sickness with no effective treatment had been rising again until DNDi began combing medical trials – some abandoned by big drug companies as not profitable – for other options. They found one promising lead and began testing in the Democratic Republic of Congo (DRC).

“The motivation, concentration and interest shown by our doctors in the DRC who were developing the clinical trial, were totally amazing. For them it was an opportunity to serve their people. And that was absolutely beautiful,” says Valverde.

The drug worked and sleeping sickness is on the way to being eradicated.

“I think this is what I always wanted to do; to do something that could be helpful to others. And this is what satisfies me. Just seeing that people have opportunities.”

Join host Imogen Foulkes on Inside Geneva to listen to the full interview.

Get in touch!

Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter.
For more stories on the international Geneva please visit www.swissinfo.ch/
Host: Imogen Foulkes
Production assitant: Claire-Marie Germain
Distribution: Sara Pasino
Marketing: Xin Zhang

  continue reading

Luvut

1. Summer profiles: unlocking treatment for neglected diseases (00:00:00)

2. Development of Drugs for Neglected Diseases (00:00:07)

3. Collaborative Approach to Neglected Diseases (00:08:42)

128 jaksoa

Artwork
iconJaa
 
Manage episode 430311887 series 2789582
Sisällön tarjoaa SWI swissinfo.ch. SWI swissinfo.ch tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Send us a text

On Inside Geneva, we bring you part three of our summer profile series. This week we talk to a doctor looking for treatments for some of the world’s most neglected diseases.
“Neglect means that there are diseases that affect an important proportion of humanity but for which no new drugs have been developed because there is no money in it. Because they affect very poor populations in remote rural areas,” explains Olaf Valverde, clinical project leader at Drugs for Neglected Diseases (DNDi).

Valverde is the clinical lead on a project looking for treatments for sleeping sickness.

“It’s a disease caused by a small parasite that almost always kills if untreated. During the first half of the 20th century there were huge epidemics. It not only destroyed communities but also caused the desertification of entire regions of Africa,” he adds.

Cases of sleeping sickness with no effective treatment had been rising again until DNDi began combing medical trials – some abandoned by big drug companies as not profitable – for other options. They found one promising lead and began testing in the Democratic Republic of Congo (DRC).

“The motivation, concentration and interest shown by our doctors in the DRC who were developing the clinical trial, were totally amazing. For them it was an opportunity to serve their people. And that was absolutely beautiful,” says Valverde.

The drug worked and sleeping sickness is on the way to being eradicated.

“I think this is what I always wanted to do; to do something that could be helpful to others. And this is what satisfies me. Just seeing that people have opportunities.”

Join host Imogen Foulkes on Inside Geneva to listen to the full interview.

Get in touch!

Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter.
For more stories on the international Geneva please visit www.swissinfo.ch/
Host: Imogen Foulkes
Production assitant: Claire-Marie Germain
Distribution: Sara Pasino
Marketing: Xin Zhang

  continue reading

Luvut

1. Summer profiles: unlocking treatment for neglected diseases (00:00:00)

2. Development of Drugs for Neglected Diseases (00:00:07)

3. Collaborative Approach to Neglected Diseases (00:08:42)

128 jaksoa

Wszystkie odcinki

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas